|
2013 Journal Article Role of human papillomaviruses in esophageal squamous cell carcinomaLiyanage, Surabhi S., Segelov, Eva, Garland, Suzanne M., Tabrizi, Sepehr N., Seale, Holly, Crowe, Philip J., Dwyer, Dominic E., Barbour, Andrew, Newall, Anthony T., Malik, Aisha and Macintyre, C. Raina (2013). Role of human papillomaviruses in esophageal squamous cell carcinoma. Asia-Pacific Journal of Clinical Oncology, 9 (1), 12-28. doi: 10.1111/j.1743-7563.2012.01555.x |
|
2013 Journal Article Impact of postoperative morbidity on long-term survival after oesophagectomyHii, M. W., Smithers, B. M., Gotley, D. C., Thomas, J. M., Thomson, I., Martin, I. and Barbour, A. P. (2013). Impact of postoperative morbidity on long-term survival after oesophagectomy. British Journal of Surgery, 100 (1), 95-104. doi: 10.1002/bjs.8973 |
|
2012 Journal Article Pancreatic cancer genomes reveal aberrations in axon guidance pathway genesBiankin, Andrew V., Waddell, Nicola, Kassahn, Karin S., Gingras, Marie-Claude, Muthuswamy, Lakshmi B., Johns, Amber L., Miller, David K., Wilson, Peter J., Patch, Ann-Marie, Wu, Jianmin, Chang, David K., Cowley, Mark J., Gardiner, Brooke B., Song, Sarah, Harliwong, Ivon, Idrisoglu, Senel, Nourse, Craig, Nourbakhsh, Ehsan, Manning, Suzanne, Wani, Shivangi, Gongora, Milena, Pajic, Marina, Scarlett, Christopher J., Gill, Anthony J., Pinho, Andreia V., Rooman, Ilse, Anderson, Matthew, Holmes, Oliver, Leonard, Conrad ... Grimmond, Sean M. (2012). Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature, 491 (7424), 399-405. doi: 10.1038/nature11547 |
|
2012 Journal Article Surgical management in patients with pancreatic cancer: a Queensland perspectiveWylie, Neil, Adib, Reza, Barbour, Andrew P., Fawcett, Jonathan, Hill, Alexander, Lynch, Stephen, Martin, Ian, O'Rourke, Thomas R., Puhalla, Harald, Rutherford, Leigh, Slater, Kellee, Whiteman, David C., Neale, Rachel E. and Queensland Pancreatic Cancer Study Group (2012). Surgical management in patients with pancreatic cancer: a Queensland perspective. ANZ Journal of Surgery, 83 (11), 859-864. doi: 10.1111/j.1445-2197.2012.06312.x |
|
2012 Journal Article Clinical issues in oesophageal adenocarcinoma: could DNA copy number hold the key?Frankel, Adam, Nancarrow, Derek, Wayte, Nicola and Barbour, Andrew (2012). Clinical issues in oesophageal adenocarcinoma: could DNA copy number hold the key?. Anz Journal of Surgery, 82 (9), 599-606. doi: 10.1111/j.1445-2197.2012.06144.x |
|
2012 Journal Article Modeling the cost-effectiveness of strategies for treating esophageal adenocarcinoma and high-grade dysplasiaGordon, Louisa G., Hirst, Nicholas G., Mayne, George C., Watson, David I., Bright, Timothy, Cai, Wang, Barbour, Andrew P., Smithers, Bernard M., Whiteman, David C. and Eckermann, Simon (2012). Modeling the cost-effectiveness of strategies for treating esophageal adenocarcinoma and high-grade dysplasia. Journal of Gastrointestinal Surgery, 16 (8), 1451-1461. doi: 10.1007/s11605-012-1911-9 |
|
2012 Journal Article An innovative approach for locally advanced stage III cutaneous melanoma: radiotherapy, followed by nodal dissectionFoote, Matthew, Burmeister, Bryan, Dwyer, Patrick, Burmeister, Elizabeth, Lambie, Duncan, Allan, Christopher, Barbour, Andrew, Bayley, Gerard, Pullar, Andrew, Meakin, Janelle, Thomas, Janine and Smithers, Mark (2012). An innovative approach for locally advanced stage III cutaneous melanoma: radiotherapy, followed by nodal dissection. Melanoma Research, 22 (3), 257-262. doi: 10.1097/CMR.0b013e3283531335 |
|
2012 Journal Article Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitorsAndersen, Jesper B., Spee, Bart, Blechacz, Boris R., Avital, Itzhak, Komuta, Mina, Barbour, Andrew, Conner, Elizabeth A., Gillen, Matthew C., Roskams, Tania, Roberts, Lewis R., Factor, Valentina M. and Thorgeirsson, Snorri S. (2012). Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors. Gastroenterology, 142 (4), 1021-1031.e15. doi: 10.1053/j.gastro.2011.12.005 |
|
2012 Conference Publication DOCTOR: A randomized phase II trial of preoperative cisplatin, 5-fluorouracil, and docetaxel with or without radiotherapy based on poor early response to standard chemotherapy for resectable adenocarcinoma of the esophagus and/or OG junctionBarbour, Andrew, Smithers, Bernard Mark, Burmeister, Bryan, Zalcberg, John Raymond, Spry, Nigel, Smith, Garrett, Wilson, Kate, Roff, Kate, Yip, Sonia and Walpole, Euan Thomas (2012). DOCTOR: A randomized phase II trial of preoperative cisplatin, 5-fluorouracil, and docetaxel with or without radiotherapy based on poor early response to standard chemotherapy for resectable adenocarcinoma of the esophagus and/or OG junction. 48th Annual Meeting of the American Society of Clinical Oncology (ASCO), Chicago, Il United States, 01-06 June 2012. Alexandria, VA United States: American Society of Clinical Oncology. |
|
2012 Journal Article Management of loco-regionally recurrent melanomaGeere, Simone L. and Barbour, Andrew P. (2012). Management of loco-regionally recurrent melanoma. Cancer Forum, 36 (3), 166-170. |
|
2012 Conference Publication Gene expression analysis of EAC in association with PET response.Wayte, Nicola, Nancarrow, Derek, Walpole, Euan Thomas, Lampe, Guy, Gotley, David, Smithers, Bernard Mark and Barbour, Andrew (2012). Gene expression analysis of EAC in association with PET response.. ASCO GI Symposium, San Diego, California, 24 January 2012. Alexandria, VA, United States: American Society of Clinical Oncology. doi: 10.1200/jco.2012.30.4_suppl.50 |
|
2011 Journal Article Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysisSjoquist, Katrin M., Burmeister, Bryan H., Smithers, B. Mark, Zalcberg, John R., Simes, R. John, Barbour, Andrew, Gebski, Val and for the Australasian Gastro-Intestinal Trials Group (2011). Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncology, 12 (7), 681-692. doi: 10.1016/S1470-2045(11)70142-5 |
|
2011 Journal Article Defining cure for esophageal cancer: Analysis of actual 5-year survivors following esophagectomyHirst, Jodi, Smithers, Bernard Mark, Gotley, David C., Thomas, Janine and Barbour, Andrew (2011). Defining cure for esophageal cancer: Analysis of actual 5-year survivors following esophagectomy. Annals of Surgical Oncology, 18 (6), 1766-1774. doi: 10.1245/s10434-010-1508-z |
|
2011 Journal Article Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trialBurmeister, Bryan H., Thomas, Janine M., Burmeister, Elizabeth A., Walpole, Euan T., Harvey, Jennifer A., Thomson, Damien B., Barbour, Andrew P., Gotley, David C. and Smithers, B. Mark (2011). Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial. European Journal of Cancer, 47 (3), 354-360. doi: 10.1016/j.ejca.2010.09.009 |
|
2011 Conference Publication Genomic and genetic characterization of human Cholangiocarcinoma identifies treatment options for tyrosine kinase inhibitorsAndersen, Jesper B., Spee, Bart, Blechacz, Boris, Avital, Itzhak, Komuta, Mina, Barbour, Andrew, Roskams, Tania, Roberts, Lewis R., Factor, Valentina M. and Thorgeirsson, Snorri S. (2011). Genomic and genetic characterization of human Cholangiocarcinoma identifies treatment options for tyrosine kinase inhibitors. 62nd Annual Meeting of the American Association for the Study of Liver Diseases, San Francisco, CA, United States, 04-08 November 2011. |
|
2011 Journal Article Biomarkers in oesophagogastric cancersCameron, Andrew, Barbour, Andrew, Wayte, Nicci and Akhurst, Tim (2011). Biomarkers in oesophagogastric cancers. Cancer Forum, 35 (3), 160-166. |
|
2010 Journal Article Risk stratification for early esophageal adenocarcinoma: Analysis of lymphatic spreadBarbour, Andrew P., Jones, Mark, Brown, Ian, Gotley, David C., Martin, Ian, Thomas, Janine, Clouston, Andre and Smithers, B. Mark (2010). Risk stratification for early esophageal adenocarcinoma: Analysis of lymphatic spread. Annals of Surgical Oncology, 17 (9), 2494-2502. doi: 10.1245/s10434-010-1025-0 |
|
2010 Journal Article Thoracoscopic-assisted esophagectomy for esophageal cancer: Analysis of patterns and prognostic factors for recurrenceThomson, Iain G., Smithers, Bernard M., Gotley, David C., Martin, Ian, Thomas, Janine M., O'Rourke, Peter and Barbour, Andrew P. (2010). Thoracoscopic-assisted esophagectomy for esophageal cancer: Analysis of patterns and prognostic factors for recurrence. Annals of Surgery, 252 (2), 281-291. doi: 10.1097/SLA.0b013e3181e909a2 |
|
2009 Journal Article Isolated limb infusion for malignant melanoma: Predictors of response and outcomeBarbour, A. P., Thomas, J., Suffolk, J., Beller, E. and Smithers, B. M, (2009). Isolated limb infusion for malignant melanoma: Predictors of response and outcome. Annals of Surgical Oncology, 16 (12), 3463-3472. doi: 10.1245/s10434-009-0717-9 |
|
2009 Journal Article Prognostic value maximum standardized uptake value from preoperative positron emission tomography in resectable adenocarcinoma of the esophagus treated by surgery aloneShenfine, J., Barbour, A. P., Wong, D., Martin, I., Gotley, D. C. and Smithers, B. M. (2009). Prognostic value maximum standardized uptake value from preoperative positron emission tomography in resectable adenocarcinoma of the esophagus treated by surgery alone. Diseases of the Esophagus, 22 (8), 668-675. doi: 10.1111/j.1442-2050.2009.00941.x |
